Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2019-01-29

Clinical Trial Update: Fluoroquinolone Associated Disability

View source ↗

Summary

Update on safety concerns related to fluoroquinolone antibiotics and the potential risk of disability, affecting patients treated for bronchitis, sinusitis, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • Levofloxacin (Levofloxacin)
  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Bronchitis, Sinusitis | Status: COMPLETED